Supplemental Figure 3 from Isorhapontigenin (ISO) Inhibits Invasive Bladder Cancer Formation <i>In Vivo</i> and Human Bladder Cancer Invasion <i>In Vitro</i> by Targeting STAT1/FOXO1 Axis
Guosong Jiang(Union Hospital), Chuanshu Huang(Wenzhou Medical University), Jiayan Gu(Wenzhou Medical University), Xingruo Zeng(New York University), Honglei Jin(Jiangxi University of Traditional Chinese Medicine), Amy D. Wu(New York University), Xin Liao(Beijing University of Posts and Telecommunications), Chao Huang(Nantong University), Haishan Huang(Wenzhou Medical University), Dongyun Zhang(Army Medical University), Jingxia Li(New York University), Haojie Huang(Tongji Hospital)
Cited by 0
Related Papers
CircHIPK3 sponges miR‐558 to suppress heparanase expression in bladder cancer cells
|EMBO Reports|2017|596
Experimental and DFT insights of the Zn-doping effects on the visible-light photocatalytic water splitting and dye decomposition over Zn-doped BiOBr photocatalysts
|Applied Catalysis B: Environmental|2018|238
LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2
|Cancer Letters|2016|230
Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations
|Nature Genetics|2014|208
Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells
|Proceedings of the National Academy of Sciences|1998|201